Suchergebnisse - "Andersen, Jan Terje"

PubPharm (13)

1

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

enthalten in: Nature communications | 2024

von Foss, S. | Sakya, S. | Aguinagalde, L. | +22

2

Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models

enthalten in: Science (New York, N.Y.) | 2023

von Mukadam, A. | Miller, L. | Smith, A. | +21

3

Assessing developability early in the discovery process for novel biologics

enthalten in: mAbs | 2023

von Fernández-Quintero, M. | Ljungars, A. | Waibl, F. | +13

4

Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice : Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody

enthalten in: ImmunoHorizons | 2022

von Mørtberg, T. | Zhi, H. | Vidarsson, G. | +9

5

In silico proof of principle of machine learning-based antibody design at unconstrained scale

enthalten in: mAbs | 2022

von Akbar, R. | Robert, P. | Weber, C. | +16

6

Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies

enthalten in: mAbs | 2022

von Akbar, R. | Bashour, H. | Rawat, P. | +12

7

NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies

enthalten in: mAbs | 2020

von Lau, C. | McAdam, M. | Bergseth, G. | +8

8

Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003

enthalten in: European journal of nuclear medicine and molecular imaging | 2019

von Maaland, A. | Heyerdahl, H. | O'Shea, A. | +5

9

Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2016

von Foss, S. | Grevys, A. | Sand, K. | +6

10

Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2015

von Grevys, A. | Bern, M. | Foss, S. | +7